25,973 results on '"Imatinib mesylate"'
Search Results
2. Precision Cancer Therapy in Rare Cancers (MATRIX-Rare)
3. Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
4. Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
5. A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor
6. Standard Chemotherapy With or Without Nelarabine or Rituximab in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (UKALL14)
7. Ruxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase Inhibitors
8. Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT (GMALL-EVOLVE)
9. Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
10. A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
11. Trial of Imatinib for Hospitalized Adults With COVID-19
12. A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL.
13. Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
14. Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
15. Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (TIPI)
16. Protocol Number: HJKC3-0003. Treatment Free Remission After Combination Therapy With Asciminib (ABL001) Plus Tyrosine Kinase Inhibitors (TKI) in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
17. A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)
18. Imatinib TDM in GIST
19. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
20. Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase (ALERTCML)
21. Asciminib Roll-over Study
22. Ipilimumab and Imatinib Mesylate in Advanced Cancer
23. I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients (I-SPY_COVID)
24. A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
25. A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL
26. Pilot Study of Imatinib Cetuximab Combo for H & N Cancer
27. Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
28. Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
29. Vactosertib and Imatinib Combination in Patients With Advanced Desmoid Tumor/Aggressive Fibromatosis (DT/AF) (MP-VAC-206)
30. Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)
31. Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
32. Late presentation of chronic myeloid leukaemia patients in a low-income country: the prognostic implications and impact on treatment outcome.
33. Chronic Myeloid Leukemia with a Rare Philadelphia Chromosome Variant Involving Chromosome 16.
34. Late presentation of chronic myeloid leukaemia patients in a low-income country: the prognostic implications and impact on treatment outcome
35. Use of a pH-responsive imatinib mesylate sustained-release hydrogel for the treatment of tendon adhesion by inhibiting PDGFRβ/CLDN1 pathway
36. Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL (LALPh2022)
37. Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population (TOKIN)
38. Study of Imatinib Discontinuation in Chronic Myeloid Leukemia With Deep Molecular Response (EDI-PIO)
39. MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
40. KISS Study: Kinase Inhibition With Sprycel Start up (KISS)
41. Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease
42. A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
43. Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia
44. Three Versus Five Years of Adjuvant Imatinib as Treatment of Patients With Operable GIST
45. Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
46. A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
47. Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML
48. A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin (IMPACT-TB)
49. Entacapone Combination With Imatinib for Treatment of GIST
50. Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial (CATCO)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.